Pharmaceutical giant Gilead Sciences has agreed to donate drugs that reduce the risk of HIV transmission for up to 200,000 people a year, the Trump administration says.
The agreement between Gilead and the Trump administration will last until at least Dec. 31, 2025, and possibly through the end of 2030, Health and Human Services Secretary Alex Azar said in a statement Thursday. Gilead will donate its PrEP medication Truvada, which is used to reduce the risk of HIV infection and usually sells for $1,600 to $2,000 a month in the United States.
The deal will “help us achieve our goal of ending the HIV epidemic in America!,” President Donald Trump said in a tweet.
About the Author
Ask AI to help you....LOL!
so you are blowing air for no reason at all? you have nothing to complain about, you just complain? you…
If you were not a Come-Here you would already know. Read the article above and put the comments below into…
Explain - what was better back then and what is bothering you about now. Be specific.
Damn shame what you people have done to Cape Charles.